Nuclear export of the influenza virus ribonucleoprotein complex: Interaction of Hsc70 with viral proteins M1 and NS2

FEBS Open Bio

Volumn 4, Issue , 2014, Pages 683-688

  Watanabe, Ken ^a   Shimizu, Teppei ^a   Noda, Saiko ^a   Tsukahara, Fujiko ^b   Maru, Yoshiro ^b   Kobayashi, Nobuyuki ^a,c  

^a NAGASAKI UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c AVSS CORPORATION   (Japan)

Author keywords

Dissociation constant; Hsc70; Influenza virus; M1; NS2; Nuclear export

Indexed keywords

ADENOSINE TRIPHOSPHATASE; GLUTATHIONE; HEAT SHOCK COGNATE PROTEIN 70; NONSTRUCTURAL PROTEIN 2; PROTEIN M1; RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; M1 PROTEIN;

AMINO TERMINAL SEQUENCE; ANTIVIRAL RESISTANCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; DELETION MUTANT; INFLUENZA VIRUS; NONHUMAN; NUCLEAR EXPORT SIGNAL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; WILD TYPE; BINDING AFFINITY; CYTOPLASM; DISSOCIATION CONSTANT; HOST CELL; PROGENY;

ORTHOMYXOVIRIDAE;

EID: 84904870343     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2014.07.004     Document Type: Article

References (37)

1. Stegmann T. Membrane fusion mechanisms: the influenza hemagglutinin paradigm and its implications for intracellular fusion. Traffic 2000, 1:598-604.
2. Herz C., Stavnezer E., Krug R., Gurney T. Influenza virus, an RNA virus, synthesizes its messenger RNA in the nucleus of infected cells. Cell 1981, 26:391-400.
3. Hutchinson E.C., Fodor E. Nuclear import of the influenza A virus transcriptional machinery. Vaccine 2012, 30:7353-7358.
4. Momose F., Kikuchi Y., Komase K., Morikawa Y. Visualization of microtubule-mediated transport of influenza viral progeny ribonucleoprotein. Microbes Infect. 2007, 9:1422-1433.
5. Kawaguchi A., Matsumoto K., Nagata K. YB-1 functions as a porter to lead influenza virus ribonucleoprotein complexes to microtubules. J. Virol. 2012, 86:11086-11095.
6. Rossman J.S., Lamb R.A. Influenza virus assembly and budding. Virology 2011, 411:229-236.
7. Martin K., Helenius A. Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 1991, 67:117-130.
8. Bui M., Wills E.G., Helenius A., Whittaker G.R. Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins. J. Virol. 2000, 74:1781-1786.
9. Fornerod M., Ohno M., Yoshida M., Mattaj I.W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 1997, 90:1051-1060.
10. Iwatsuki-Horimoto K., Horimoto T., Fujii Y., Kawaoka Y. Generation of influenza A virus NS2 (NEP) mutants with an altered nuclear export signal sequence. J. Virol. 2004, 78:10149-10155.
11. Huang S., Chen J., Chen Q., Wang H., Yao Y., Chen J., Chen Z. A second CRM1-dependent nuclear export signal in the influenza A virus NS2 protein contributes to the nuclear export of viral ribonucleoproteins. J. Virol. 2013, 87:767-778.
12. Cao S., Liu X., Yu M., Li J., Jia X., Bi Y., Sun L., Gao G.F., Liu W. A nuclear export signal in the matrix protein of Influenza A virus is required for efficient virus replication. J. Virol. 2012, 86:4883-4891.
13. Yu M., Liu X., Cao S., Zhao Z., Zhang K., Xie Q., Chen C., Gao S., Bi Y., Sun L., Ye X., Gao G.F., Liu W. Identification and characterization of three novel nuclear export signals in the influenza A virus nucleoprotein. J. Virol. 2012, 86:4970-4980.
14. Watanabe K., Takizawa N., Katoh M., Hoshida K., Kobayashi N., Nagata K. Inhibition of nuclear export of ribonucleoprotein complexes of influenza virus by leptomycin B. Virus Res. 2001, 77:31-42.
15. Elton D., Simpson-Holley M., Archer K., Medcalf L., Hallam R., McCauley J., Digard P. Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway. J. Virol. 2001, 75:408-419.
16. Kudo N., Matsumori N., Taoka H., Fujiwara D., Schreiner E.P., Wolff B., Yoshida M., Horinouchi S. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:9112-9117.
17. Shimizu T., Takizawa N., Watanabe K., Nagata K., Kobayashi N. Crucial role of the influenza virus NS2 (NEP) C-terminal domain in M1 binding and nuclear export of vRNP. FEBS Lett. 2011, 585:41-46.
18. Yasuda J., Nakada S., Kato A., Toyoda T., Ishihama A. Molecular assembly of influenza virus: association of the NS2 protein with virion matrix. Virology 1993, 196:249-255.
19. Akarsu H., Burmeister W.P., Petosa C., Petit I., Muller C.W., Ruigrok R.W., Baudin F. Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2). EMBO J. 2003, 22:4646-4655.
20. O'Neill R.E., Talon J., Palese P. The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J. 1998, 17:288-296.
21. Neumann G., Hughes M.T., Kawaoka Y. Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1. EMBO J. 2000, 19:6751-6758.
22. Boulo S., Akarsu H., Ruigrok R.W., Baudin F. Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes. Virus Res. 2007, 124:12-21.
23. Ma K., Roy A.M., Whittaker G.R. Nuclear export of influenza virus ribonucleoproteins: identification of an export intermediate at the nuclear periphery. Virology 2001, 282:215-220.
24. Watanabe K., Fuse T., Asano I., Tsukahara F., Maru Y., Nagata K., Kitazato K., Kobayashi N. Identification of Hsc70 as an influenza virus matrix protein (M1) binding factor involved in the virus life cycle. FEBS Lett. 2006, 580:5785-5790.
25. Perez-Vargas J., Romero P., Lopez S., Arias C.F. The peptide-binding and ATPase domains of recombinant hsc70 are required to interact with rotavirus and reduce its infectivity. J. Virol. 2006, 80:3322-3331.
26. Tsukahara F., Maru Y. Identification of novel nuclear export and nuclear localization-related signals in human heat shock cognate protein 70. J. Biol. Chem. 2004, 279:8867-8872.
27. Watanabe K., Takizawa N., Noda S., Tsukahara F., Maru Y., Kobayashi N. Hsc70 regulates the nuclear export but not the import of influenza viral RNP: a possible target for the development of anti-influenza virus drugs. Drug Discov. Ther. 2008, 2:77-84.
28. Tsukahara F., Yoshioka T., Muraki T. Molecular and functional characterization of HSC54, a novel variant of human heat-shock cognate protein 70. Mol. Pharmacol. 2000, 58:1257-1263.
29. Stuart J.K., Myszka D.G., Joss L., Mitchell R.S., McDonald S.M., Xie Z., Takayama S., Reed J.C., Ely K.R. Characterization of interactions between the anti-apoptotic protein BAG-1 and Hsc70 molecular chaperones. J. Biol. Chem. 1998, 273:22506-22514.
30. Kwon O.S., Churchich J.E. Interaction of 70-kDA heat shock cognate protein with peptides and myo-inositol monophosphatase. J. Biol. Chem. 1994, 269:266-271.
31. Ye Z.P., Baylor N.W., Wagner R.R. Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides. J. Virol. 1989, 63:3586-3594.
32. Robb N.C., Smith M., Vreede F.T., Fodor E. NS2/NEP protein regulates transcription and replication of the influenza virus RNA genome. J. Gen. Virol. 2009, 90:1398-1407.
33. Odagiri T., Tobita K. Mutation in NS2, a nonstructural protein of influenza A virus, extragenically causes aberrant replication and expression of the PA gene and leads to generation of defective interfering particles. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:5988-5992.
34. Manz B., Brunotte L., Reuther P., Schwemmle M. Adaptive mutations in NEP compensate for defective H5N1 RNA replication in cultured human cells. Nat. Commun. 2012, 3:802.
35. Hayden F.G. Antiviral resistance in influenza viruses - implications for management and pandemic response. N. Engl. J. Med. 2006, 354:785-788.
36. Stephenson I., Democratis J., Lackenby A., McNally T., Smith J., Pareek M., Ellis J., Bermingham A., Nicholson K., Zambon M. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children. Clin. Infect. Dis. 2009, 48:389-396.
37. Kiso M., Mitamura K., Sakai-Tagawa Y., Shiraishi K., Kawakami C., Kimura K., Hayden F.G., Sugaya N., Kawaoka Y. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 2004, 364:759-765.